Literature DB >> 951465

The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency.

C W Ogle, P Turner, H Markomihelakis.   

Abstract

The effects of oral oxprenolol (320 mg) or propranolol (240 or 320 mg) and of diazepam (5 mg) or lorazepam (2 mg) on pursuit rotor performance, reaction time and critical flicker frequency were investigated in healthy subjects in 3 separate studies. A 240-mg dose of propranolol significantly impaired pursuit rotor performance but not 320 mg of propranolol or oxprenolol. Both beta-adrenoceptor blockers did not affect reaction time or critical flicker frequency. Diazepam impaired pursuit rotor performance and reaction time, but not critical flicker frequency. Lorazepam generally impaired all three parameters. The findings suggest that it is possible for beta-adrenoceptor blockers to depress skeletal muscle activity without having a central effect, as shown by impairment of CNS function tests which rely also on muscle coordination but not of those relying only on central activity. These results also show that single oral doses of oxprenolol or propranolol, as high as 320 mg, do not have central effects, and support the belief that small anxiolytic doses of these blockers exert their actions through peripheral blockade of beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 951465     DOI: 10.1007/bf00421117

Source DB:  PubMed          Journal:  Psychopharmacologia


  23 in total

1.  The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat.

Authors:  W C BOWMAN; E ZAIMIS
Journal:  J Physiol       Date:  1958-11-10       Impact factor: 5.182

2.  Propranolol on tests of visual function and central nervous activity.

Authors:  P C Bryan; D O Efiong; J Stewart-Jones; P Turner
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

3.  Effects of beta adrenergic blockade with sotalol in chronic anxiety.

Authors:  P J Tyrer; M H Lader
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

4.  Anxiety and beta-adrenergic blockade.

Authors:  W N Stone; G C Gleser; L A Gottschalk
Journal:  Arch Gen Psychiatry       Date:  1973-11

5.  Debrisoquine, guanethidine, propranolol and human sleep.

Authors:  D L Dunleavy; A W MacLean; I Oswald
Journal:  Psychopharmacologia       Date:  1971

6.  Tranquillizing effects of propranolol demonstrated in rats.

Authors:  J G Bainbridge; D T Greenwood
Journal:  Neuropharmacology       Date:  1971-07       Impact factor: 5.250

7.  CNS effects of propranolol in man.

Authors:  M H Orzack; R Branconnier; G Gardos
Journal:  Psychopharmacologia       Date:  1973

8.  The effect of propranolol on anxiety.

Authors:  K L Granville-Grossman; P Turner
Journal:  Lancet       Date:  1966-04-09       Impact factor: 79.321

9.  Peripheral beta-adrenergic receptors concerned with tremor.

Authors:  C D Marsden; T H Foley; D A Owen; R G McAllister
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

10.  Response to propranolol and diazepam in somatic and psychic anxiety.

Authors:  P J Tyrer; M H Lader
Journal:  Br Med J       Date:  1974-04-06
View more
  17 in total

1.  Diazepam and delta-9-THC: contrasting effects on the discrimination of speech sounds in nonhuman primates.

Authors:  R D Hienz; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.

Authors:  J Sonne; M Døssing; S Loft; K L Olesen; A Vollmer-Larsen; M A Victor; O Hamberg; H Thyssen
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

4.  Some clinical pharmacological studies with terfenadine, a new antihistamine drug.

Authors:  V K Kulshrestha; P P Gupta; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

5.  Beta-blockers and psychometric performance: studies in normal volunteers.

Authors:  D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Drugs, alcohol and driving.

Authors:  T Seppala; M Linnoila; M J Mattila
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

7.  Metipranolol and propranolol: no CNS effects of a single oral dose.

Authors:  S Levander; A Gillner
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 8.  Biomarkers for the effects of benzodiazepines in healthy volunteers.

Authors:  S J de Visser; J P van der Post; P P de Waal; F Cornet; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

9.  Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

Authors:  Vassilis Koudas; Alexandra Nikolaou; Eugenia Hourdaki; Stella G Giakoumaki; Panos Roussos; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

10.  Central effects of single oral doses of propranolol in man.

Authors:  S A Salem; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.